{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:23:45Z","timestamp":1780086225114,"version":"3.54.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijcme-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Metabolic & Endocrine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijcme.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T17:20:49Z","timestamp":1420824049000},"page":"24-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A circulating biomarker risk-prediction model correlates with CHADS-2 risk score in chronic atrial fibrillation"],"prefix":"10.1016","volume":"6","author":[{"given":"Smita I.","family":"Negi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Greener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashish","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Samuel C.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcme.2015.01.002_bb0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0010","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0015","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0025","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk scores for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0040","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjcard.2004.04.070","article-title":"Predictive values of indices of inflammation and hypercoaguability on success of cardioversion in persistent atrial fibrillation","volume":"94","author":"Conway","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0050","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1373\/clinchem.2006.083923","article-title":"Oxidative stress markers are associated with persistent atrial fibrillation","volume":"53","author":"Neuman","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0055","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.105.538108","article-title":"Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases","volume":"112","author":"Dudley","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0060","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/01.CIR.0000039327.11661.16","article-title":"Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke","volume":"106","author":"Cai","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0065","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/jn\/131.12.3208","article-title":"Bioavailability and antioxidant activity of some food supplements in men and women using the DROM tests as a marker of oxidative stress","volume":"131","author":"Cornelli","year":"2001","journal-title":"J Nutr."},{"key":"10.1016\/j.ijcme.2015.01.002_bb0070","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1194\/jlr.R800037-JLR200","article-title":"Isoprostanes","volume":"50","author":"Roberts","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0075","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1540-8159.2009.02339.x","article-title":"Atrial fibrillation and CHADS-2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently","volume":"32","author":"Crandall","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2010.02.066","article-title":"Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population","volume":"56","author":"Marott","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0085","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","article-title":"High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with non valvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis","volume":"38","author":"Lip","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0100","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2012.04812.x","article-title":"High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation","volume":"10","author":"Rold\u00e1n","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amjcard.2011.08.010","article-title":"Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study)","volume":"109","author":"Hermida","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0110","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2003.11.062","article-title":"Relationship of interleukin-6 and C reactive protein to the prothrombotic state in chronic atrial fibrillation","volume":"43","author":"Conway","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/187152910793743850","article-title":"Atrial fibrillation: the emerging role of inflammation and oxidative stress","volume":"10","author":"Negi","year":"2010","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yjmcc.2011.09.018","article-title":"Metabolic stress, reactive oxygen species, and arrhythmia","volume":"52","author":"Jeong","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","article-title":"The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation","volume":"115","author":"Korantzopoulos","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/hrt.2007.135277","article-title":"Endothelial dysfunction and pathophysiological correlates in atrial fibrillation","volume":"95","author":"Guazzi","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jacc.2007.07.085","article-title":"Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery","volume":"51","author":"Kim","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcme.2015.01.002_bb0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.thromres.2009.05.018","article-title":"Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells","volume":"124","author":"Jaulmes","year":"2009","journal-title":"Thromb Res"}],"container-title":["IJC Metabolic & Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214762415000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214762415000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T13:43:48Z","timestamp":1566222228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214762415000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"alternative-id":["S2214762415000031"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcme.2015.01.002","relation":{},"ISSN":["2214-7624"],"issn-type":[{"value":"2214-7624","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A circulating biomarker risk-prediction model correlates with CHADS-2 risk score in chronic atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"IJC Metabolic & Endocrine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcme.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}